PDF(Pubmed)
Abstract：
Essential thrombocythemia is the category of myeloproliferative syndromes, generally characterized by a group of clonal stem cell diseases that present a disturbance in the growth of one or more sets of hematopoietic cells. All long clinical treatment, patients may experience gastrointestinal disorders and other metabolic processes that can lead to weight loss and malnutrition. Cytokine is involved in the control of appetite, digestive, and metabolic processes in the body, it can be assumed that increased stimulation could impair the control of these processes leading to loss of body mass. Effective and systematic nutritional intervention is required to ensure patient compliance with treatment and improved nutritional status.
摘要：
原发性血小板增多症是骨髓增生综合征的类别，通常以一组克隆干细胞疾病为特征，这些疾病对一组或多组造血细胞的生长造成干扰。所有长期的临床治疗，患者可能会经历胃肠道疾病和其他代谢过程，从而导致体重减轻和营养不良。细胞因子参与控制食欲，消化性,和体内的代谢过程，可以认为，增加的刺激可能会削弱对这些过程的控制，从而导致体重下降。需要有效和系统的营养干预，以确保患者对治疗的依从性和改善营养状况。
